| A priority paper for the societal and ethical aspects of synthetic biology M Schmidt, A Ganguli-Mitra, H Torgersen, A Kelle, A Deplazes, ... Systems and synthetic biology 3, 3-7, 2009 | 121 | 2009 |
| Synthetic biology: the technoscience and its societal consequences M Schmidt, A Kelle, A Ganguli-Mitra, H De Vriend Springer Science & Business Media, 2009 | 104 | 2009 |
| What does it mean to be made vulnerable in the era of COVID-19? A Ahmad, R Chung, L Eckenwiler, A Ganguli-Mitra, M Hunt, R Richards, ... The Lancet 395 (10235), 1481-1482, 2020 | 70 | 2020 |
| Ethical norms and the international governance of genetic databases and biobanks: findings from an international study AM Capron, A Mauron, BS Elger, A Boggio, A Ganguli-Mitra, ... Kennedy Institute of Ethics Journal 19 (2), 101-124, 2009 | 62 | 2009 |
| SYNBIOSAFE e-conference: online community discussion on the societal aspects of synthetic biology M Schmidt, H Torgersen, A Ganguli-Mitra, A Kelle, A Deplazes, ... Systems and Synthetic Biology 2, 7-17, 2008 | 53 | 2008 |
| Vulnerability in healthcare and research ethics A Ganguli-Mitra, N Biller-Andorno The Sage handbook of health care ethics: Core and emerging issues, 239-250, 2011 | 33 | 2011 |
| Charting regulatory stewardship in health research: Making the invisible visible GT Laurie, ES Dove, A Ganguli-Mitra, I Fletcher, C McMillan, N Sethi, ... Cambridge Quarterly of Healthcare Ethics 27 (2), 333-347, 2018 | 22 | 2018 |
| Of Newtons and heretics A Ganguli-Mitra, M Schmidt, H Torgersen, A Deplazes, N Biller-Andorno Nature biotechnology 27 (4), 321-322, 2009 | 22 | 2009 |
| Reconfiguring social value in health research through the lens of liminality A Ganguli‐Mitra, ES Dove, GT Laurie, S Taylor‐Alexander Bioethics 31 (2), 87-96, 2017 | 18 | 2017 |
| Beyond regulatory compression: confronting the liminal spaces of health research regulation S Taylor-Alexander, ES Dove, I Fletcher, A Ganguli Mitra, C McMillan, ... Law, Innovation and Technology 8 (2), 149-176, 2016 | 17 | 2016 |
| Vulnerability and exploitation in a globalized world AG Mitra, N Biller-Andorno IJFAB: International Journal of Feminist Approaches to Bioethics 6 (1), 91-102, 2013 | 17 | 2013 |
| The ethics of synthetic biology: outlining the agenda A Deplazes, A Ganguli-Mitra, N Biller-Andorno Synthetic Biology: The technoscience and its societal consequences, 65-79, 2010 | 17 | 2010 |
| Digitally supported public health interventions through the lens of structural injustice: The case of mobile apps responding to violence against women and girls E Sauerborn, K Eisenhut, A Ganguli‐Mitra, V Wild Bioethics 36 (1), 71-76, 2022 | 15 | 2022 |
| Off‐Shoring Clinical Research: Exploitation and the Reciprocity Constraint AG Mitra Developing World Bioethics 13 (3), 111-118, 2013 | 14 | 2013 |
| Guidelines on biobanks: emerging consensus and unresolved controversies E Vayena, A Ganguli-Mitra, N Biller-Andorno Ethical Issues in Governing Biobanks, 23-35, 2016 | 13 | 2016 |
| Segmenting communities as public health strategy: a view from the social sciences and humanities A Ganguli-Mitra, I Young, L Engelmann, I Harper, D McCormack, ... Wellcome Open Research 5, 2020 | 12 | 2020 |
| Sex selection and global gender justice A Ganguli-Mitra Journal of Social Philosophy, 2021 | 9 | 2021 |
| Benefit-sharing and Remuneration A Ganguli-Mitra Ethical Issues in Governing Biobanks, 217-229, 2016 | 9 | 2016 |
| Collective consent A Ganguli-Mitra Ethical Issues in Governing Biobanks, 121-130, 2016 | 7 | 2016 |
| Justice and the racial dimensions of health inequalities: A view from COVID‐19 A Ganguli‐Mitra, K Qureshi, GD Curry, N Meer Bioethics 36 (3), 252-259, 2022 | 6 | 2022 |
Markus SchmidtBiofaction KGVerified email at biofaction.com
